2. Academic Validation
  3. Dioscin inhibiting EGFR-mediated Survivin expression promotes apoptosis in oral squamous cell carcinoma cells

Dioscin inhibiting EGFR-mediated Survivin expression promotes apoptosis in oral squamous cell carcinoma cells

  • J Cancer. 2023 Jul 9;14(11):2027-2038. doi: 10.7150/jca.85011.
Ming Li 1 2,  Qin Zhao 1 2,  Jinzhuang Liao 3,  Xiaocong Wang 1 2,  Lulu Liu 1 2,  Xiaoyue Zhang 1 2,  Lijun Liu 4,  Haidan Liu 4,  Shusheng Zhang 1 2
Affiliations

Affiliations

  • 1 Changsha Stomatological Hospital, Changsha, Hunan 410004, China.
  • 2 School of Stomatology, Hunan University of Chinese Medicine, Changsha, Hunan 410208, China.
  • 3 Department of Radiology, The Third Xiangya Hospital of Central South University, Changsha, Hunan 410013, China.
  • 4 Clinical Center for Gene Diagnosis and Therapy, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China.
PMID: 37497406 DOI: 10.7150/jca.85011
Abstract

Overexpression of Survivin plays a crucial role in tumorigenesis and correlates with poor prognosis in human malignancies, including oral squamous cell carcinoma (OSCC). Thus, Survivin has been proposed as an attractive target for new antitumor interventions. In the present study, we found that a natural compound, Dioscin, inhibited OSCC cells by reducing the Survivin protein level and activating apoptotic signaling. Dioscin inhibits Survivin expression by interrupting EGFR binding to the AT-rich sequences (ATRSs) at the Survivin promoter, eventually promoting survivin-mediated cell Apoptosis. The in vivo study showed that Dioscin suppressed the tumor development of SCC25 cells. Furthermore, the immunohistochemistry (IHC) results revealed that treated with Dioscin reduced the protein levels of EGFR and Survivin in SCC25 xenograft tumors. Overall, our findings indicate that targeting the EGFR-survivin axis might be a promising OSCC treatment strategy.

Keywords

Dioscin; EGFR; apoptosis; oral squamous cell carcinoma; survivin.

Figures
Products